These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 8211041

  • 1. [Hemorrheology and quality of life in fibrinogen- and lipid-lowering therapy].
    Walzl M, Lechner H, Walzl B, Kleinert G, Schied G, Freidl W, Bertha G.
    Schweiz Med Wochenschr; 1993 Oct 09; 123(40):1875-82. PubMed ID: 8211041
    [Abstract] [Full Text] [Related]

  • 2. [Heparin-induced extracorporeal LDL precipitation (HELP). A new therapeutic possibility in cerebral multi-infarct dementia].
    Walzl M, Walzl B, Kleinert G, Schied G, Lechner H.
    Nervenarzt; 1993 Oct 09; 64(10):648-52. PubMed ID: 8232678
    [Abstract] [Full Text] [Related]

  • 3. [Hemorheology and H.E.L.P. in multi-infarct dementia].
    Lechner H, Walzl M, Walzl B.
    Wien Klin Wochenschr; 1992 Oct 09; 104(10):290-3. PubMed ID: 1534954
    [Abstract] [Full Text] [Related]

  • 4. [Association between fibrinogen and blood sedimentation rate in combined extracorporal and fibrinogen reducing drug therapy].
    Walzl M, Walzl B, Schied G, Lechner H.
    Wien Klin Wochenschr; 1993 Oct 09; 105(14):404-7. PubMed ID: 8367976
    [Abstract] [Full Text] [Related]

  • 5. [H.E.L.P. (heparin-induced extracorporeal LDL precipitation) and bezafibrate--a new therapeutic combination in cerebrovascular diseases].
    Walzl M, Walzl B, Kleinert G, Schied H, Lechner H.
    Vasa Suppl; 1992 Oct 09; 37():85-7. PubMed ID: 1481114
    [No Abstract] [Full Text] [Related]

  • 6. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F, Jaeger BR, Oberhoffer M, Reichart B, Seidel D.
    Z Kardiol; 2003 Oct 09; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [Abstract] [Full Text] [Related]

  • 7. [Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia].
    Vázquez-Chávez C, Salinas-Orozco S, Gómez-Díaz RA, Rosso-Juárez MM, Moreno-Vázquez K, Nissen-Torres T, Argüero-Sánchez R.
    Rev Invest Clin; 1998 Oct 09; 50(6):491-6. PubMed ID: 10070221
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 09; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 9. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness].
    Walch C, Anderhuber W, Walzl M.
    Laryngorhinootologie; 1996 Nov 09; 75(11):641-5. PubMed ID: 9063830
    [Abstract] [Full Text] [Related]

  • 10. The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot study.
    Mathur S, Barradas MA, Mikhailidis DP, Dandona P.
    Diabetes Res; 1990 Jul 09; 14(3):133-8. PubMed ID: 2132185
    [Abstract] [Full Text] [Related]

  • 11. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 09; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 12. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B, Walzl M, Lechner P, Lechner H, Cesnik H.
    Wien Med Wochenschr; 1993 Dec 09; 143(22):563-70. PubMed ID: 8154130
    [Abstract] [Full Text] [Related]

  • 13. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Dec 09; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 14. A promising approach to the treatment of multi-infarct dementia.
    Walzl M.
    Neurobiol Aging; 2000 Dec 09; 21(2):283-7. PubMed ID: 10867212
    [Abstract] [Full Text] [Related]

  • 15. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
    Cortellaro M, Cofrancesco E, Boschetti C, Cortellaro F, Mancini M, Mariani M, Paoletti R.
    Thromb Haemost; 2000 Apr 09; 83(4):549-53. PubMed ID: 10780315
    [Abstract] [Full Text] [Related]

  • 16. Effect of heparin-induced extracorporeal low-density lipoprotein precipitation and bezafibrate on hemorheology and clinical symptoms in cerebral multiinfarct disease.
    Walzl M.
    Haemostasis; 1993 Apr 09; 23(4):192-202. PubMed ID: 8314169
    [Abstract] [Full Text] [Related]

  • 17. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M.
    Clin Endocrinol (Oxf); 2004 Jul 09; 61(1):113-22. PubMed ID: 15212653
    [Abstract] [Full Text] [Related]

  • 18. Cost of lipid lowering in patients with coronary artery disease by case method learning.
    Kiessling A, Zethraeus N, Henriksson P.
    Int J Technol Assess Health Care; 2005 Jul 09; 21(2):180-6. PubMed ID: 15921057
    [Abstract] [Full Text] [Related]

  • 19. Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function.
    Xue J, Dong Q, Han X, You H, Gu Y, Lin S.
    Ther Apher Dial; 2007 Jun 09; 11(3):171-6. PubMed ID: 17497997
    [Abstract] [Full Text] [Related]

  • 20. Blood rheology changes during bezafibrate treatment.
    Caimi G, Francavilla G, Romano A, Catania A, Santonocito G, Sarno A.
    Br J Clin Pract; 1988 Nov 09; 42(11):456-8. PubMed ID: 3076782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.